CHESTERBROOK, Pa.--(BUSINESS WIRE)--Neuraptive Therapeutics today announced the appointment of Ulf Wiinberg to its Board of Directors and William “Bill” MacKenzie as Senior Vice President – Finance.
NEW ORLEANS — The oral nonpeptide GLP-1 receptor agonist orforglipron (Foundayo, Eli Lilly) showed greater A1c reduction and weight loss in people with type 2 diabetes (T2D) than both dapagliflozin ...
NEW ORLEANS -- Once-daily orforglipron (Foundayo) improved outcomes in adults with type 2 diabetes and inadequate glycemic control, the international ACHIEVE-5 trial showed. In patients already taking ...
Glucose levels were monitored before and after injection using blood glucose strips (FasTake, LifeScan). For insulin sensitivity, mice were fasted for 4 h and injected intraperitoneally with regular ...
Lifescan Imaging Private Limited is a Non-govt company, incorporated on 22 Sep, 2004. It's a private unlisted company and is classified as'company limited by shares'. Company's authorized capital ...
Lifescan Healthcare Private Limited is a Non-govt company, incorporated on 23 Dec, 2010. It's a private unlisted company and is classified as'company limited by shares'. Company's authorized capital ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results